Skip to main content
Clinical Trials/NL-OMON52034
NL-OMON52034
Recruiting
Not Applicable

Multicenter Randomized Clinical Trial to Assess the Effect of Active versus Passive Recharge Burst Spinal Cord Stimulation on Pain Relief in Failed Back Surgery - Active vs. passibe burst in FBSS

Rijnstate Ziekenhuis0 sites94 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronische pijn veroorzaakt door failed back surgery syndrome.
Sponsor
Rijnstate Ziekenhuis
Enrollment
94
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Rijnstate Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Subject of either gender between 18 and 65 years of age
  • Al least moderate level of catastrophizing as measured with the Pain
  • catastrophizing score (PCS) of at least 20\.\[23]
  • History consistent with FBSS of at least 6 months
  • Neurologic exam without marked motor deficit.
  • Low Back Pain or leg pain intensity should be 5 or higher measured with the
  • 11\-box NRS 0\-10
  • Meets all the inclusion criteria for the implantation of a neurostimulation
  • system as typically utilized in the study center. PM: depression is not an
  • exclusion criteria

Exclusion Criteria

  • Female subject of childbearing potential is pregnant/nursing or plans to
  • become pregnant during the course of the study
  • Escalating or changing pain condition within the past month as evidenced by
  • investigator examination
  • BMI \>\=35
  • Subject has had injection therapy or radiofrequency treatment for their low
  • back pain within the past 3 months
  • Subject currently has an active implantable device including ICD, pacemaker,
  • spinal cord stimulator or intrathecal drug pump
  • Subject is unable to operate the device

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19
EUCTR2020-001530-35-ESFundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)450
Active, not recruiting
Phase 1
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for PatientsWith Acute Ischemic Stroke Due to Tandem LesioAcute Ischemic StrokeMedDRA version: 22.1Level: LLTClassification code: 10055221Term: Ischemic stroke Class: 10029205MedDRA version: 20.0Level: SOCClassification code: 10047065Term: Vascular disorders Class: 12MedDRA version: 20.0Level: HLGTClassification code: 10003216Term: Arteriosclerosis stenosis vascular insufficiency and necrosis Class: 10047065MedDRA version: 22.1Level: PTClassification code: 10061256Term: Ischaemic stroke Class: 100000004852MedDRA version: 20.0Level: HLTClassification code: 10008192Term: Cerebrovascular and spinal necrosis and vascular insufficiency Class: 10047065Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
CTIS2023-508454-26-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla240
Recruiting
Not Applicable
Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2MutationsC50C56Malignant neoplasm of breastMalignant neoplasm of ovary
DRKS00005736Klinikum rechts der Isar der TU München, Frauenklinik60
Completed
Phase 3
Multicenter Randomized Controlled Trial to Assess the Necessity of Second-look Endoscopy after Endoscopic Submucosal Dissection (ESD) for gastric neoplasms: the SAFE studyearly gastric cancer/gastric adenoma
JPRN-UMIN000007170Graduate School of Medicine, University of Tokyo250
Active, not recruiting
Not Applicable
Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma
EUCTR2015-001801-15-ESFIBICO